Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Robert Alexander, PhD$93.1M
Market Cap • 18/04/20242012
(há 12 anos)
2018
(6 years ago)
NASDAQ
Listagem
San Carlos
Sede • California123
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ALLKSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.